• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (61)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurology  • Multiple Sclerosis/ Demyelinating Disease  • Radiologic Imaging  • Magnetic Resonance Imaging  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Massimiliano Calabrese, MD; Nicola De Stefano, MD, PhD; Matteo Atzori, MD; Valentina Bernardi, MD; Irene Mattisi, MD; Luigi Barachino, PhD; Aldo Morra, MD; Luciano Rinaldi, MD, PhD; Chiara Romualdi, PhD; Paola Perini, MD; Leontino Battistin, MD; Paolo Gallo, MD, PhD

Arch Neurol. 2007;64(10):1416-1422.

Background  A significant inflammatory pathologic disorder in the cortex of patients with multiple sclerosis (MS) has been demonstrated by ex vivo studies.

Objective  To determine the frequency, time of appearance, and clinical relevance of intracortical lesions (ICLs) in MS in vivo.

Design  Double inversion recovery sequence study.

Setting  Multiple Sclerosis Centre of the Veneto Region.

Patients  We enrolled 380 patients (116 with clinically isolated syndrome [CIS], 163 with relapsing-remitting MS [RRMS], and 101 with secondary progressive MS [SPMS]) and 40 age- and sex-matched healthy volunteers between May 1, 2005, and December 31, 2006.

Main Outcome Measures  We assessed the frequency and number of ICLs and brain parenchyma fraction, white matter T2 lesion volume, and clinical disability.

Results  Although never observed in healthy volunteers, ICLs were detected in 58% of patients (36% of patients with CIS, 64% of patients with RRMS, and 73% of patients with SPMS). The number of ICLs was higher in patients with SPMS than in those with CIS or RRMS (P <.001), and patients with ICLs had a higher Expanded Disability Status Scale score (P = .004), a higher white matter T2 lesion volume (P = .008), a lower brain parenchyma fraction (P = .009), and a higher frequency of IgG oligoclonal bands (IgGOBs) (P <.001) than patients without ICLs. Patients positive for IgGOBs had more ICLs than patients negative for IgGOBs (P = .02). The number of ICLs correlated with the Expanded Disability Status Scale score (r = 0.48, P <.001), white matter T2 lesion volume (r = 0.38, P = .001), and brain parenchyma fraction (r = –0.47, P = .001). A significant association between ICLs and male sex was observed.

Conclusions  Although more frequent in patients with SPMS, ICLs were observed from the early disease stages. The ICLs were more frequently detected in patients with IgGOBs and were associated with a higher clinical disability score and male sex. The ICLs may help to define MS clinical heterogeneity and prognosis in clinical settings.

Author Affiliations: The Multiple Sclerosis Centre of the Veneto Region–First Neurology Clinic, Department of Neurosciences, University Hospital of Padova (Drs Calabrese, Atzori, Bernardi, Mattisi, Rinaldi, Perini, Battistin, and Gallo), Neuroradiology Unit, Euganea Medica (Drs Barachino, Morra, and Battistin), and CRIBI–Biotechnology Centre and Department of Biology, University of Padova (Drs Romualdi and Battistin), Padova; Quantitative Neuroimaging Laboratory, Department of Neurological and Behavioral Sciences, University of Siena, Siena (Drs De Stefano and Battistin); and IRCCS Hospital San Camillo, Venezia (Dr Battistin), Italy.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Modelling the distribution of cortical lesions in multiple sclerosis
Sormani et al.
Mult Scler 2012;18:229-231.
ABSTRACT | FULL TEXT  

The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis
Calabrese et al.
Mult Scler 2012;18:174-180.
ABSTRACT | FULL TEXT  

Postmortem verification of MS cortical lesion detection with 3D DIR
Seewann et al.
Neurology 2012;78:302-308.
ABSTRACT | FULL TEXT  

MS cortical lesions on double inversion recovery MRI: Few but true
Ciccarelli and Chen
Neurology 2012;78:296-297.
FULL TEXT  

Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study
Calabrese et al.
J. Neurol. Neurosurg. Psychiatry 2012;83:49-54.
ABSTRACT | FULL TEXT  

Cortical Diffusion-Tensor Imaging Abnormalities in Multiple Sclerosis: A 3-year Longitudinal Study
Calabrese et al.
Radiology 2011;261:891-898.
ABSTRACT | FULL TEXT  

Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis
Seewann et al.
Mult Scler 2011;17:1202-1210.
ABSTRACT | FULL TEXT  

The predictive value of gray matter atrophy in clinically isolated syndromes
Calabrese et al.
Neurology 2011;77:257-263.
ABSTRACT | FULL TEXT  

Predicting the development of multiple sclerosis: Is gray matter a missing piece of the puzzle?
Chard and Geurts
Neurology 2011;77:210-211.
FULL TEXT  

MR Imaging of Multiple Sclerosis
Filippi and Rocca
Radiology 2011;259:659-681.
ABSTRACT | FULL TEXT  

Identification and Clinical Impact of Multiple Sclerosis Cortical Lesions as Assessed by Routine 3T MR Imaging
Mike et al.
Am. J. Neuroradiol. 2011;32:515-521.
ABSTRACT | FULL TEXT  

Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography
Saidha et al.
Brain 2011;134:518-533.
ABSTRACT | FULL TEXT  

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI
Geurts et al.
Neurology 2011;76:418-424.
ABSTRACT | FULL TEXT  

No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study
Rinaldi et al.
J. Neurol. Neurosurg. Psychiatry 2010;81:1345-1350.
ABSTRACT | FULL TEXT  

Brain macro- and microscopic damage in patients with paediatric MS
Absinta et al.
J. Neurol. Neurosurg. Psychiatry 2010;81:1357-1362.
ABSTRACT | FULL TEXT  

Intracortical lesions: Relevance for new MRI diagnostic criteria for multiple sclerosis
Filippi et al.
Neurology 2010;75:1988-1994.
ABSTRACT | FULL TEXT  

Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis
Calabrese et al.
Neurology 2010;75:1234-1240.
ABSTRACT | FULL TEXT  

T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis
Bagnato et al.
Mult Scler 2010;16:1203-1212.
ABSTRACT  

MR Imaging of Gray Matter Involvement in Multiple Sclerosis: Implications for Understanding Disease Pathophysiology and Monitoring Treatment Efficacy
Filippi and Rocca
Am. J. Neuroradiol. 2010;31:1171-1177.
ABSTRACT | FULL TEXT  

Structural and Functional Hippocampal Changes in Multiple Sclerosis Patients with Intact Memory Function
Roosendaal et al.
Radiology 2010;255:595-604.
ABSTRACT | FULL TEXT  

Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis
Calabrese et al.
J. Neurol. Neurosurg. Psychiatry 2010;81:401-404.
ABSTRACT | FULL TEXT  

Widespread cortical thinning characterizes patients with MS with mild cognitive impairment
Calabrese et al.
Neurology 2010;74:321-328.
ABSTRACT | FULL TEXT  

In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI
Mainero et al.
Neurology 2009;73:941-948.
ABSTRACT | FULL TEXT  

What you see depends on how you look: Gray matter lesions in multiple sclerosis
Chard and Miller
Neurology 2009;73:918-919.
FULL TEXT  

Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis
Calabrese et al.
Arch Neurol 2009;66:1144-1150.
ABSTRACT | FULL TEXT  

Magnetic resonance evidence of cortical onset of multiple sclerosis
Calabrese and Gallo
Mult Scler 2009;15:933-941.
ABSTRACT  

MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction
Anderson et al.
Mult Scler 2009;15:811-817.
ABSTRACT  

Accumulation of cortical lesions in MS: relation with cognitive impairment
Roosendaal et al.
Mult Scler 2009;15:708-714.
ABSTRACT  

Cortical lesions in primary progressive multiple sclerosis: A 2-year longitudinal MR study
Calabrese et al.
Neurology 2009;72:1330-1336.
ABSTRACT | FULL TEXT  

Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study
Calabrese et al.
Mult Scler 2009;15:36-41.
ABSTRACT  

Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives
Bar-Zohar et al.
Mult Scler 2008;14:719-727.
ABSTRACT